Literature DB >> 29516950

Mechanisms correlated with chemotherapy resistance in tongue cancers.

Guanghong Han1, Chengbi Xu2, Dan Yu2.   

Abstract

Tongue cancer is one of the most common and deadly types of head and neck cancer. The incidence of tongue cancer has been particularly high and remained been increasing in some countries. A main reason for poor prognosis and clinical outcome for tongue cancer was its resistance to chemotherapies, behind which the mechanisms have been not clear. In this review, we summarized literatures published in recent years and listed the proteins, biomacromolecules, and signaling pathways related to this drug resistance. We hoped that this summary could provide reference for researchers to develop new treatment strategies for tongue cancer.

Entities:  

Keywords:  Resistance; tongue cancer; treatment

Mesh:

Substances:

Year:  2018        PMID: 29516950     DOI: 10.4103/jcrt.JCRT_763_17

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  6 in total

1.  Relationship between CD44high/CD133high/CD117high cancer stem cells phenotype and Cetuximab and Paclitaxel treatment response in head and neck cancer cell lines.

Authors:  Ana Livia Silva Galbiatti-Dias; Glaucia Maria Mendonça Fernandes; Marcia Maria Urbanin Castanhole-Nunes; Luiza Fernandes Hidalgo; Carlos Henrique Viesi Nascimento Filho; Rosa Sayoko Kawasaki-Oyama; Leticia Antunes Muniz Ferreira; Patricia Matos Biselli-Chicote; Érika Cristina Pavarino; Eny Maria Goloni-Bertollo
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

2.  Oral tongue carcinoma: prognostic changes according to the updated 2020 version of the AJCC/UICC TNM staging system.

Authors:  Marta Tagliabue; Rita De Berardinis; Pietro Belloni; Sara Gandini; Donatella Scaglione; Fausto Maffini; Rosolino Antonino Mirabella; Stefano Riccio; Giugliano Gioacchino; Roberto Bruschini; Francesco Chu; Mohssen Ansarin
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-04       Impact factor: 2.618

3.  Exosomal miR-200c suppresses chemoresistance of docetaxel in tongue squamous cell carcinoma by suppressing TUBB3 and PPP2R1B.

Authors:  Jun Cui; Haiyan Wang; Xiaohe Zhang; Xiaodong Sun; Jin Zhang; Jinji Ma
Journal:  Aging (Albany NY)       Date:  2020-04-20       Impact factor: 5.682

4.  Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study.

Authors:  A Marra; M Violati; F Broggio; C Codecà; M Blasi; A Luciani; S Zonato; D Rabbiosi; L Moneghini; A Saibene; A Maccari; G Felisati; D Ferrari
Journal:  Acta Otorhinolaryngol Ital       Date:  2019-04       Impact factor: 2.124

5.  Treatment outcomes and prognostic factors in oral tongue cancer: a 20-year retrospective study at the National Cancer Center, South Korea.

Authors:  Min-Gyeong Kim; Yong-Seok Choi; Suk Min Youn; Jae-Hee Ko; Hyun Jun Oh; Jong-Ho Lee; Joo-Yong Park; Sung-Weon Choi
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2022-08-31

6.  A Novel Plant-Derived Choline Transporter-like Protein 1 Inhibitor, Amb544925, Induces Apoptotic Cell Death via the Ceramide/Survivin Pathway in Tongue Squamous Cell Carcinoma.

Authors:  Kaoru Shibata; Nozomi Nishijima; Kaho Hirai; Saiichiro Watanabe; Tsuyoshi Yamanaka; Daichi Chikazu; Masato Inazu
Journal:  Cancers (Basel)       Date:  2022-01-10       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.